VEGF

1
Assets
1
Companies

Target Biology

Competitive Landscape

Asset Company Stage Mechanism Lead Indication Ownership
TransCon_aVEGF_EYC-0305 ASND Preclinical TransCon anti-VEGF

Companies

ASND 1 asset(s)
Preclinical
← Back to All Targets